Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Bereza, BG"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 12, Pp 167-175 (2020)
Basil G Bereza, 1 Doug Coyle, 2 Derek Y So, 3 Zbigniew Kadziola, 4 George Wells, 2 Paul Grootendorst, 1 Emmanuel A Papadimitropoulos 1, 4 1University of Toronto Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada; 2University of Ottawa School of Epid
Externí odkaz:
https://doaj.org/article/f6bd26974baa4ca48cbccac62bd90db9
Publikováno v:
International Journal of COPD, Vol 2015, Iss Issue 1, Pp 739-744 (2015)
Basil G Bereza,1 Anders Troelsgaard Nielsen,2 Sverrir Valgardsson,3 Michiel EH Hemels,2 Thomas R Einarson11Leslie Dan Faculty of Pharmacy, University of Toronto, ON, Canada; 2Janssen A/S, Birkerød, Denmark; 3Janssen-Cilag A/S, Oslo, NorwayBackground
Externí odkaz:
https://doaj.org/article/e4f143145bda4fa0bcc180d9920380bd
Autor:
Bereza, BG, Coyle, D, So, DY, Kadziola, Z, Wells, G, Grootendorst, P, A, E, Papadimitropoulos
Background: Pharmacogenetic (PGx) testing identifies pharmacotherapeutic risks to permit personalized therapy. Identifying the genetic profile of patients with acute coronary syndrome (ACS) who are considered for therapy with clopidogrel (P2Y12 recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______900::4d226d585f64c17d23c752d33ef4d468
http://bura.brunel.ac.uk/handle/2438/21074
http://bura.brunel.ac.uk/handle/2438/21074
Publikováno v:
In Value in Health November 2016 19(7):A509-A509
Publikováno v:
In Value in Health November 2015 18(7):A648-A648
Publikováno v:
Annals of Pharmacotherapy; Oct2008, Vol. 42 Issue 10, p1402-1409, 8p
Publikováno v:
In Value in Health 2010 13(7):A290-A290
Publikováno v:
In Value in Health 2009 12(7):A520-A520
Publikováno v:
In Value in Health 2009 12(7):A510-A510
Publikováno v:
In Value in Health 2009 12(7):A356-A356